Prenetics Global (PRE) Income from Non-Controlling Interests (2021 - 2026)
Prenetics Global (PRE) posted quarterly Income from Non-Controlling Interests of -$365000.0 for Q1 2026, up 48.3% year-over-year from -$246122.3 in Q1 2025, and down 769.05% quarter-over-quarter from -$42000.0 in Q4 2025.
Prenetics Global (PRE) Income from Non-Controlling Interests (2021 - 2026) Analysis & Trends
Prenetics Global (PRE) has reported Income from Non-Controlling Interests for 6 consecutive years, with -$365000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Non-Controlling Interests rose 48.3% year-over-year to -$365000.0; the TTM figure through Mar 2026 stood at -$2.0 million (up 50.04% YoY), while the FY2025 annual figure was -$2.3 million, up 39.36% from the prior year.
- Income from Non-Controlling Interests fell to -$365000.0 in Q1 2026 per PRE's latest filing, from -$42000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $1.0 in Q4 2022 and bottomed at -$1.4 million in Q3 2024.
- Historically, Income from Non-Controlling Interests has averaged -$538617.3 across 5 years, with a median of -$484000.0 in 2024.
- Annual changes were most pronounced in 2022 — Income from Non-Controlling Interests jumped 103.7% — and 2023, when it tumbled 56827700.0%.
- Prenetics Global's Income from Non-Controlling Interests stood at $1.0 in 2022, then sank by 56827700.0% to -$568276.0 in 2023, then tumbled by 139.14% to -$1.4 million in 2024, then soared by 96.91% to -$42000.0 in 2025, then sank by 769.05% to -$365000.0 in 2026.
- Business Quant data shows PRE's Income from Non-Controlling Interests at -$365000.0 in Q1 2026, -$42000.0 in Q4 2025, and -$1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 5.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 2.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 400,000.00 |
| 10 | Prenetics Global | 368.73 Mn | 309.68 Mn | 30.20 Mn | 23.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.47 Mn |
| Mar 31, 2026 | -23.47 Mn |
| Dec 31, 2025 | -42,000.00 |
| Sep 30, 2025 | -1.29 Mn |
| Jun 30, 2025 | -317,000.00 |
| Mar 31, 2025 | -706,000.00 |
| Dec 31, 2024 | -3.74 Mn |
| Sep 30, 2024 | -1.40 Mn |
| Jun 30, 2024 | -561,000.00 |
| Mar 31, 2024 | -484,000.00 |
| Dec 31, 2023 | -2.05 Mn |
| Sep 30, 2023 | -559.96 Mn |
| Jun 30, 2023 | -399.88 Mn |
| Mar 31, 2023 | -1.11 Bn |
| Dec 31, 2022 | -54,000.00 |
| Sep 30, 2022 | -8,000.00 |
| Jun 30, 2022 | -1,000.00 |
| Mar 31, 2022 | -46,000.00 |
| Dec 31, 2021 | -7.57 Mn |
| Sep 30, 2021 | -2.42 Mn |